Multicentre phase II trial of bevacizumab combined with docetaxel–carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905)
Titel:
Multicentre phase II trial of bevacizumab combined with docetaxel–carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905)
Auteur:
Kim, H.R. Jung, K.H. Im, S.-A. Im, Y.-H. Kang, S.Y. Park, K.H. Lee, S. Kim, S.-B. Lee, K.-H. Ahn, J.S. Kim, S.I. Sohn, J.H.